Introduction
Many studies have indicated that lack of health insurance is associated with adverse patient outcomes. [1] [2] [3] Although lack of insurance is a barrier for medical care access overall, uninsured adults face even greater barriers for preventive services and treatment for chronic illnesses, such as cancer, than for acute care. 4 Thorpe and Howard reported that approximately 11 percent of cancer patients were uninsured. 5 An additional 15 percent had coverage through Medicaid or other public programs (not including Medicare). Rates of being uninsured or insured through public programs are greater among racial/ethnic minority populations: 14 percent of black cancer patients were uninsured and 33 percent received insurance through public programs, while the rates for Hispanic cancer patients were 20 percent uninsured and 24 percent receiving public program insurance.
Not surprisingly, individuals who are either uninsured or enrolled in Medicaid have decreased rates of cancer screening, less optimal cancer treatment patterns, and worse cancer-related outcomes compared with those with Medicare coverage or private insurance. These differences are likely attributable to multiple factors, including the following:
• out-of-pocket expenditures for uninsured patients that deter use of preventive care services and physician encounters for suspicious symptoms
• decreased appreciation of the importance of appropriate and timely followup after abnormal screening results
• difficulty in identifying both primary care and specialist physicians willing to see uninsured and Medicaid patients, and greater delays for appointments among physicians willing to see these patient groups
• greater likelihood of receiving care at safety-net hospitals, which may be less likely to have the most recent medical care technology or physicians informed about current practices and guidelines
• decreased access to newer, more expensive therapies, which are generally more effective and/or have fewer side effects
• greater difficulties in navigating health care systems, including the complex set of health care providers involved in cancer care.
Beyond the potential impacts of being uninsured or having Medicaid coverage, other forms of insurance may also be associated with decreased access to care for individuals with cancer. Private health insurance includes a tremendous range of products, some of which have substantial out-of-pocket expenses (deductibles, co-payments, and co-insurance). These costs may deter the use of preventive care services (e.g., cancer screenings) and visits with physicians to evaluate suspicious symptoms that may represent early-stage cancers. Privately insured patients with more limited benefits may also be less likely to purchase expensive new medications because of substantial patient-borne costs.
In addition, patients in traditional fee-for-service plans may differ from those in managed care plans. Managed care plans (for privately insured or Medicare-or Medicaid-covered individuals), owing to their capitated payment structures, have increased financial incentives to keep enrollees healthy and diagnose diseases early. Thus, individuals in these plans may have more incentives or support for participating in screening programs and other preventive care activities.
A substantial body of literature has investigated the relationship between health care insurance status and medical care patterns and outcomes for individuals with cancer. This research report summarizes key literature regarding the relationship between health insurance coverage and cancer care. Our main objective is to provide a summary of published results to evaluate whether providing adequate insurance coverage for uninsured and underinsured individuals (i.e., those experiencing problems in accessing care despite having health insurance) could improve outcomes for cancer patients (e.g., earlier stage at diagnosis, increased access to treatments, improved quality of life outcomes during and after treatments, increased survival). Our synthesis is not a comprehensive review of all literature on this topic; our focus is on providing an overview and highlighting the main findings in this area. The summary (presented in the Results section)
is divided into three sections: the association of insurance status with cancer screening services, with cancer stage at diagnosis, and with cancer treatment patterns and outcomes.
Methods
We identified all studies included for this literature synthesis using the National Library of Medicine's MEDLINE database. We used the Medical Subject Heading (MeSH) term Neoplasms in conjunction with the MeSH terms Insurance, Health, Medically Uninsured, or Health Services Accessibility. We included only English language articles, studies based on US populations, and studies published in the past 10 years. In addition, we also evaluated reference sections of reviewed articles to identify other studies for inclusion in this report. Study selection for inclusion in this literature synthesis was based on a comprehensive review of article titles and abstracts.
To provide an overview and highlight findings in this area, we selected only articles that clearly presented information on both patient insurance status and the specific type of cancer screening, diagnosis, treatment, or outcomes being assessed. Papers that did not clearly define different insurance status groups or did not provide information on cancer treatment patterns or outcomes separately for each insurance status group were excluded. Further, when multiple papers examined the link between insurance status and cancer treatment patterns or outcomes in the same (or very similar) populations, we included only the most recent studies. We selected the most relevant studies for full review and inclusion in this manuscript. Additionally, all articles selected for review for this report had to include multivariate statistical analyses as part of their study methodology, to control for other relevant factors while examining the potential impact of insurance status.
Results

Identified Articles
Based on the MEDLINE search parameters and review process described previously in the Methods section, we identified 25 publications providing information on the association between health insurance and cancer screening; 17 publications on insurance and cancer diagnosis; and 26 publications on insurance and cancer treatment and outcome. The literature summary presented in this section includes 15 of the articles on insurance and screening, 11 on insurance and diagnosis, and 18 on insurance and cancer treatment and outcome.
Association Between Health Insurance and Cancer Screening Services
A variety of studies have explored the relationship between insurance status and use of cancer screening services, mainly mammography, colon cancer screening, and cervical cancer screening. Studies included in this literature synthesis are summarized in Table 1 (following page). Most published studies have used data from national surveys, either the Behavioral Risk Factor Surveillance System (BRFSS) or the National Health Information Survey (NHIS). Studies in this literature synthesis are grouped below based on their source of data.
Studies Using Data from the Behavioral Risk Factor Surveillance System
The BRFSS, an annual health survey developed by the Centers for Disease Control and Prevention (CDC), is the world's largest ongoing telephonebased health survey system (http://www.cdc.gov/ brfss). Analyses of the BRFSS have consistently shown that lack of health insurance is associated with decreased rates of cancer screening. Qureshi et al. 6 assessed the effects of insurance status on the likelihood of screening mammography utilization within the preceding 2 years among women ages 40 to 49 using data from the 1992-1993 BRFSS. Separate evaluations of the impact of health insurance on screening mammography utilization were performed for four racial/ethnic groups: non-Hispanic white, non-Hispanic black, Hispanic, and other. Adjusting for potential confounders (including other accessto-care variables, demographics, and behavioral characteristics), having health insurance significantly increased the likelihood of using screening mammography among all ethnic groups except the "other" group. Ayanian et al. 7 examined rates of clinical breast examination, screening mammography, Pap smear, fecal occult blood test (FOBT), and sigmoidoscopy rates using data from the 1997-1998 BRFSS. After adjusting for potential confounders, long-term uninsured individuals were significantly less likely to have each screening service (p < 0.001) and short-term uninsured individuals were significantly less likely to have screening mammography and Pap smears (p < 0.001). Ioannou et al. 8 presented similar findings using data from the 1999 BRFSS. Echeverria and Carrasquillo 13 investigated the effect of citizenship status and health insurance on cancer screening rates, including Pap smear use among women ages 18-65 and mammograms among women ages 50-70, using 2000 NHIS data. They found that noncitizens and naturalized citizens were less likely to report mammography and Pap smears than were USborn women (p < 0.01). Yet, for mammography, the effect of citizenship status on health insurance became nonsignificant after controlling for health insurance coverage and usual source of care, suggesting that lack of health insurance coverage and a usual source of care explained the observed citizenship-based disparities.
Not only are insurance coverage and screening utilization associated, but significant differences also exist among specific insurance types regarding use of cancer screening services. Potosky et al. 14 
Studies Using Other Data Sources
A variety of other survey and data sources have been used to assess the relationship between insurance status and participation in cancer screening. In general, results are similar to those from the BRFSS and NHIS: uninsured individuals are less likely to receive cancer screening. Parker et al., 20 using Medicare data from 1993 and 1994 for female California residents ages 65 or older, also found that those with dual Medicaid and Medicare were significantly less likely than those with Medicare only to receive mammography, after controlling for race and ethnicity, age, and certain community-level factors. As noted above, these results could reflect differences in factors related to socioeconomic status and/or reimbursements between the dual and non-dual populations.
Overall, the results of these studies highlight the importance of insurance coverage as a predictor of cancer screening utilization and demonstrate that differences in utilization among uninsured compared with insured individuals persist across racial/ethnic and economic groups. Further, type of insurance affects screening utilization. Expanding coverage of adequate insurance can increase screening rates, as can programs that provide free (or low-cost) cancer screening to underserved populations. McCoy et al. 21 and others have shown that such programs can lead to the diagnosis of cancer at an earlier stage among those who participate.
Association Between Health Insurance and Cancer Stage at Diagnosis
A limited number of studies have evaluated the association between insurance status and the stage at which cancers are diagnosed. The studies examining this topic included in this literature synthesis are summarized in Table 2 and are divided in to three subsections: studies using national data; those using state-specific data; and those evaluating duration of Medicaid enrollment. In a similar analysis of patients diagnosed with oropharyngeal cancer, Chen et al. 24 reported that those presenting with advanced stage disease at diagnosis were significantly more likely to be uninsured or covered by Medicaid than to have private insurance. Uninsured and Medicaid patients were also more likely than those with private insurance to present with large tumors and greater degrees of lymph node involvement at diagnosis. Chen et al. 25 reported similar findings for patients with laryngeal cancer: those who were uninsured or had Medicaid coverage were more likely to present with advanced disease than were those with private or Medicare coverage. 
State-Specific Studies
Association Between Health Insurance and Cancer Treatment Patterns or Outcomes
Studies of the relationship between health insurance status and either cancer treatment patterns (i.e., the type of treatment received) or cancer outcomes (mainly survival) are summarized in Table 3 .
Studies of Health Insurance and Cancer Treatment Patterns
A small number of studies have analyzed associations between insurance coverage and cancer treatment using data from a single institution, single state, or group of states; the evidence from these studies is mixed. Among nine studies included, five found that uninsured or Medicaid patients were less likely than privately insured patients to receive guideline therapies. In contrast, three other studies reported no significant association between insurance status and cancer treatment patterns, and one study reported a significantly negative association. [38] [39] [40] [41] Analyzing pattern of surgery among early-stage breast cancer patients treated at a single institution from 1993-2000, Parviz et al. 38 found no association between insurance coverage and surgery treatment pattern. Harlan et al. 39 studied 11 types of cancer in the 1995-1999 National Cancer Institute Patterns of Care Study and found that lack of insurance had only a weak impact on the receipt of guideline treatments. Adherence to guidelines is a broad measure and may not be sensitive enough to pick up differences in care associated with insurance status in this population. In a small study population (N = 303) using 2001 Louisiana Cancer Registry data, Wu et al. 40 did not find a significant association of postoperative chemotherapy with insurance coverage among stage III colon cancer patients. In one study reporting a negative association, Richardson et al. 41 found that uninsured and Medicaid breast cancer patients in Florida were more likely to receive chemotherapy than were privately insured and Medicare patients among those diagnosed in nonteaching hospitals from 1997-2000. BCS = breast-conserving surgery; BMT = bone marrow transplant; CI = confidence interval; FFS = fee-for-service; GLS = generalized least-squares; HMO = health maintenance organization; HR = hazard ratio; HRQOL = health-related quality of life; NCDB = National Cancer Data Base; NCI = National Cancer Institute; PPO = preferred provider organization; SEER = Surveillance, Epidemiology, and End Results
B. Studies of Insurance Status and Cancer Outcomes
Overall, these results suggest that insurance status is not a consistent predictor of cancer treatment. However, the limited number of available studies and the potentially nongeneralizable populations included in the studies (either from single institutions or single states) make drawing firm conclusions difficult. Additional research is needed to assess more thoroughly associations between insurance status and cancer treatment patterns. Studies should evaluate relationships between insurance and both guidelinebased care and new treatment modalities.
Studies of Health Insurance and Cancer Outcome
Three of the studies reviewed in the previous section 26, 30, 37 reported that certain groups of Medicaid patients with cancer were at greater risk of death than were non-Medicaid patients. Nine additional studies included in this report also examined associations between insurance and health outcomes among cancer patients. 15, 34, 35, [42] [43] [44] [45] [46] [47] Eight of these found that uninsured or Medicaid patients had worse health outcomes than privately insured patients. 15, 35, [42] [43] [44] [45] [46] [47] Of these, three were based on data from single states. Roetzheim et al., 35 15 Okunade et al. 47 analyzed state-level data from 1990 to 1997 from a variety of sources, including the BRFSS; NCI's SEER registry; and the US Bureau of the Census. In an ecological analysis, these investigators found that breast cancer mortality was greater among women living in states with higher rates of uninsured or Medicaid populations. However, this study also reported higher breast cancer mortality rates for states with higher income or education levels. Given the ecological nature of this study (rather than patientbased analyses, as used in other studies included), it is difficult to differentiate the impact of insurance status versus breast cancer incidence (which may be greater in women with higher income/education) on breast cancer mortality.
Only one study we identified found no association between insurance coverage and survival for cancer patients. Roetzheim et al. 34 analyzed data from breast cancer patients younger than 65 diagnosed in Florida and followed through 1997. Stage-adjusted survival for uninsured and Medicaid patients was not significantly different from that of privately insured patients. In this study, the authors concluded that differences in survival by insurance status reflected differences in stage at diagnosis.
Although mortality is the final outcome measure for any condition, cause-specific mortality provides a more specific measure than does all-cause mortality. However, the studies reviewed above generally included only all-cause mortality. Cause-specific mortality is more difficult to obtain, often requiring death certificates or linkage with the National Death Index, and it does have limitations regarding the listed cause or causes of death. In assessments of associations between insurance status and cancer outcomes, evaluating morbidity and related outcomes such as health-related quality of life would also be useful. Unfortunately, almost no information is available on the association between insurance status and morbidity or quality of life among cancer patients. The one study in this area that we identified48 investigated the association of insurance coverage with quality of life among prostate cancer patients using data from the 1995-1998 CaPSURE database. CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) is a longitudinal observational study of prostate cancer patients nationwide, with more than 11,000 enrolled patients (http://www.capsure.net). This study found that lack of health insurance was associated with decreased quality of life, measured by both generic and diseasespecific instruments.
The majority of studies included in this section indicate an association between insurance status and outcomes, but many of them were unable to control fully for patient socioeconomic status. Socioeconomic status is strongly associated with health outcomes (both morbidity and mortality) and with insurance status. For that reason, caution must be exercised in attempting to link insurance status with long-term or final health outcomes without taking into account other relevant patient characteristics.
populations. Although the majority of uninsured cancer patients likely have incomes that are too low to purchase health insurance, a minority of this population (particularly younger adults) may choose not to purchase insurance despite having adequate income. 49, 50 The privately insured population comprises individuals with a tremendous range of plan types, each with variation in covered services, out-of-pocket expenses, lifetime expenditure limitations, and pre-approval requirements. Clearly, having private insurance does not necessarily imply that all needed cancer-related services are covered; many private insurance plans may be inadequate, and cancer patients with these plans find themselves to be underinsured.
Few studies have assessed associations between insurance status and cancer treatment patterns or outcomes. The main outcome studied with respect to insurance status is all-cause mortality, which is not likely to differentiate the impact of treatment patterns or quality of care as specifically as would cause-specific mortality. Little information is available on the relationship between insurance status and delays in care, which are likely to affect both stage at diagnosis and patient outcome. Further, studies combining patients with different cancer types and/or insurance types into a single group may miss associations of individual cancer or insurance types with treatment patterns and health outcomes. For example, studies that analyzed the association of insurance status and compliance with guideline-approved therapies among multiple types of cancer combined may not detect some effects because insurance status may affect compliance with treatment guidelines differently by type of cancer.
Multiple barriers other than insurance status also affect receipt of timely medical care. These include both patient factors (e.g., low interest in screening, lack of trust in the health care system) and healthsystem factors (e.g., availability of information in formats or languages that can be understood by patients, ease of transportation to medical care facilities). Although our literature synthesis indicates that lack of adequate insurance is an important factor regarding decreased use of cancer screening services and is probably associated with decreased medical
Discussion
Although the literature summarized in this synthesis provides somewhat mixed evidence, the overall finding is that insurance status is significantly associated with use of cancer screening services, cancer stage at diagnosis, and survival outcomes.
The relationship between insurance status and cancer treatment patterns or outcomes is less clear, but a relationship likely exists for certain types of treatment.
The studies we included have several strengths. Using data from a diverse range of sources and differing geographic regions, they generally found similar results. Several studies used data from national health care surveys or large-scale registries, and so they are generalizable to the entire US cancer population or to large subsets of this population. Many of the analyses found significant impacts of insurance status while controlling for sociodemographic factors such as race or ethnicity, income, and/or education.
Multiple limitations are associated with the studies reviewed. Many studies involved patients from a single institution or state, and they have limited generalizability on their own. Insurance status, the characteristics on which this literature synthesis focused, is based on self-report in some studies (e.g., those using data from national health care surveys) and may be subject to bias. Even in those studies with verified information on health insurance status (e.g., based on hospital billing information), there is little or no information on the duration of insurance coverage before cancer diagnosis, the type of preventive or screening services covered by the insurance, and the deductibles, co-payments, and other out-of-pocket expenses that may influence use of cancer screening, diagnostic, and treatment services. Several studies included only limited insurance status groups; for example, several studies included only Medicare patients. Even though comparisons between individuals with Medicare alone versus those with dual Medicare-Medicaid coverage are important, these results are not likely to be generalizable to younger cancer patients.
Further, the insurance status groups examined in the reviewed studies do not represent homogenous care quality and outcomes, addressing lack of health insurance or inadequate insurance alone is unlikely to resolve all disparities in cancer screening and treatment.
The reviewed studies strongly indicate that insurance status is associated with screening utilization and early diagnoses, and it may be associated with treatment and its outcomes. In particular, individuals with private insurance and/or Medicare coverage are more likely to have greater utilization of cancer screening services, to be diagnosed at earlier stages, and to have better clinical outcomes than do those who are uninsured or have Medicaid coverage. More research is needed to evaluate fully the effects of type of insurance status on outcomes of screening and subsequent cancer patient care. Links between these components of care must be explored, to understand the mechanisms by which insurance status affects stage at diagnosis, treatment patterns, and outcomes. For example, do lack of insurance and other factors affecting access to care lead to delays in follow-up from abnormal screening results or scheduling of timely and high quality cancer treatment?
4. Hafner-Eaton C. Physician utilization disparities between the uninsured and insured. comparisons of the chronically ill, acutely ill, and well nonelderly populations. JAMA. 1993;269:787-92.
Finally, the research suggests that the benefits of extending appropriate insurance coverage to uninsured and underinsured individuals could be substantial. These benefits are likely to include reduced morbidity, improved quality of life, and increased survival for cancer patients as well as a positive impact on overall health care and societal costs.
Conclusions
Individuals who are uninsured or have insurance coverage through Medicaid programs are significantly less likely to receive cancer screening services and significantly more likely to present with advanced stage cancer at diagnosis. These individuals also have significantly worse survival. The available evidence (from fewer studies) also suggests that uninsured cancer patients are likely to receive less optimal treatment. Providing appropriate and adequate insurance coverage for all uninsured and underinsured individuals will likely expand cancer screening for underserved populations, increase prevention and early detection of cancer, and improve outcomes for cancer patients.
